The U.S. Food and Drug Administration gave De Novo clearance to Techsomed's BioTraceIO, which leverages a computational algorithm to analyze ultrasound images captured during liver ablation treatment ...

Chicago — Surgical resection is the standard of care for small colorectal liver metastases, but the results of a phase 3 trial reported at the American Society of Clinical Oncology (ASCO) 2024 annual ...

Fusion imaging integrates pre-procedural cross-sectional datasets—such as contrast-enhanced computed tomography and magnetic resonance imaging—with real-time ultrasonography to guide percutaneous ...

Depending on the stage and severity of liver cancer, treatment options range from surgery and ablation to radiation, embolization, and drug therapies like immunotherapy and chemotherapy. For early ...

Thermal ablation demonstrated noninferiority to surgical resection for small colorectal liver metastases, with comparable overall survival and local control outcomes. The COLLISION trial showed ...

DNA cytometric parameters as prognostic factors of chemoimmunotherapy for ovarian cancer. This is an ASCO Meeting Abstract from the 2017 ASCO Annual Meeting I. This abstract does not include a full ...

Microwave ablation (MWA) of colorectal liver metastases (CRLM) had low rates of failure and morbidity and warrants consideration as definitive treatment, authors of a large clinical review suggested.

Surgery and radiofrequency ablation showed similar 5-year survival rates for small liver tumors. Both treatments had nearly identical 5-year recurrence-free survival outcomes. Patient and tumor ...

Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally ...

The treatment plan for liver cancer can vary depending on the stage, size, and location of the tumor. Common options include surgery, ablation, cryotherapy, immunotherapy, and targeted drug therapy.